Bibliography

Found 86 results
Filters: Author is Letendre, S  [Clear All Filters]
2019
Kallianpur AR, Gittleman H, Letendre S, Ellis R, Barnholtz-Sloan JS, Bush WS, Heaton R, Samuels DC, Franklin DR, Rosario-Cookson D, et al. Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection. Mol Neurobiol. 2019 ;56(5):3808-3818.
Perez-Valero I, Ellis RJ, Heaton RK, Deutsch R, Franklin D, Clifford DB, Collier AC, Gelman B, Marra C, McCutchan JA, et al. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects. AIDS. 2019 ;33(3):475-481.
Livelli A, Vaida F, Ellis RJ, Ma Q, Ferrara M, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, et al. Correlates of HIV RNA concentrations in cerebrospinal fluid during antiretroviral therapy: a longitudinal cohort study. Lancet HIV. 2019 ;6(7):e456-e462.
Saloner R, Campbell LM, Serrano V, Montoya JL, Pasipanodya E, Paolillo EW, Franklin D, Ellis RJ, Letendre S, Collier AC, et al. Neurocognitive SuperAging in Older Adults Living With HIV: Demographic, Neuromedical and Everyday Functioning Correlates. Journal of the International Neuropsychological Society [Internet]. 2019 . Available from: https://www.cambridge.org/core/terms. https://doi.org/10.1017/S1355617719000018
Smieszek S, Jia P, Samuels DC, Zhao Z, Barnholtz-Sloan JS, Kaur H, Letendre S, Ellis RJ, Franklin D, Hulgan T, et al. Nuclear-Mitochondrial interactions influence susceptibility to HIV-associated neurocognitive impairment. Mitochondrion. 2019 ;46:247-255.
2017
Mehta SR, Pérez-Santiago J, Hulgan T, Day TRC, Barnholtz-Sloan JS, Gittleman H, Letendre S, Ellis RJ, Heaton RK, Patton SM, et al. Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment. J Neuroinflammation. 2017 ;14(1):72.
Patton SM, Wang Q, Hulgan T, Connor JR, Jia P, Zhao Z, Letendre S, Ellis RJ, Bush WS, Samuels DC, et al. Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults. Fluids Barriers CNS. 2017 ;14(1):11.
Kaur H, Bush W, Letendre S, Ellis R, Heaton R, Patton S, J C, Samuels D, Hulgan T, Kallianpur A. CNS iron status is associated with neurocognitive function over time in HIV+ adults. 2017 .
Kaur H, Hulgan T, Fennema-Notestine C, Smieczek S, Letendre S, Ellis RJ, Bush WS, Soontornniyomkij V, Moore D, Masliah E, et al. Common SNPs in the HFE (hemochromatosis) gene are associated with neurocognitive impairment and aging-related neurodegenerative processes in HIV+ adults. 2017 .
Curley P, Rajoli RKR, Moss DM, Liptrott NJ, Letendre S, Owen A, Siccardi M. Efavirenz Is Predicted To Accumulate in Brain Tissue: an In Silico, In Vitro, and In Vivo Investigation. Antimicrob Agents Chemother. 2017 ;61(1).
Obermeit LC, Beltran J, Casaletto KB, Franklin D, Letendre S, Ellis RJ, Fennema-Notestine C, Vaida F, Collier AC, Marra CM, et al. Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND. J Neurovirol. 2017 ;23(1):67-78.
Jia P, Zhao Z, Hulgan T, Bush WS, Samuels DC, Bloss C, Heaton RK, Ellis RJ, Schork N, Marra CM, et al. Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study. Am J Med Genet B Neuropsychiatr Genet. 2017 ;174(4):413-426.
Ubaida-Mohien C, Lamberty B, Dickens AM, Mielke MM, Marcotte TD, Sacktor N, Grant I, Letendre S, Franklin D, Cibrowski P, et al. Modifications in acute phase and complement systems predict shifts in cognitive status of HIV-infected patients. AIDS. 2017 ;31(10):1365-1378.
Yuen T, Brouillette M-J, Fellows LK, Ellis RJ, Letendre S, Heaton RK, Mayo N. Personalized Risk Index for Neurocognitive Decline Among People With Well-Controlled HIV Infection. J Acquir Immune Defic Syndr. 2017 ;76(1):48-54.
Anderson AM, Muñoz-Moreno JA, McClernon DR, Ellis RJ, Cookson DRosario, Clifford DB, Collier AC, Gelman B, Marra CM, McArthur JC, et al. Prevalence and Correlates of Persistent HIV-1 RNA in Cerebrospinal Fluid During Antiretroviral Therapy. J Infect Dis. 2017 ;215(1):105-113.
2016
Kallianpur AR, Wang Q, Jia P, Hulgan T, Zhao Z, Letendre S, Ellis RJ, Heaton RK, Franklin D, Barnholtz-Sloan JS, et al. Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era. J Infect Dis. 2016 ;213(7):1065-73.
Cooley SA, Paul RH, Fennema-Notestine C, Morgan EE, Vaida F, Deng Q, Chen JAshley, Letendre S, Ellis RJ, Clifford DB, et al. Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals. J Neurovirol. 2016 ;22(5):607-614.
Samuels DC, Kallianpur AR, Ellis RJ, Bush WS, Letendre S, Franklin D, Grant I, Hulgan T. European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection. Pathog Immun. 2016 ;1(2):330-351.
Fields J, Serger E, Campos S, Divakaruni AS, Kim C, Smith K, Trejo M, Adame A, Spencer B, Rockenstein E, et al. HIV alters neuronal mitochondrial fission/fusion in the brain during HIV-associated neurocognitive disorders. Neurobiol Dis. 2016 ;86:154-69.
Wagner GA, Chaillon A, Liu S, Franklin D, Caballero G, Pond SLK, Vaida F, Heaton RK, Letendre S, Grant I, et al. HIV-associated neurocognitive disorder is associated with HIV-1 dual infection. AIDS. 2016 ;30(17):2591-2597.
Edén A, Marcotte TD, Heaton RK, Nilsson S, Zetterberg H, Fuchs D, Franklin D, Price RW, Grant I, Letendre S, et al. Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment. PLoS One. 2016 ;11(6):e0157160.

Pages